HCA Healthcare profit guidance cut
Analysis based on 6 articles · First reported Jul 20, 2026 · Last updated Jul 24, 2026
HCA's stock dropped over 6% after the guidance cut, reflecting investor disappointment. The investigation by KTMC may lead to further negative sentiment and potential legal costs for HCA.
On July 14, 2026, HCA Healthcare, Inc. issued a press release reporting its preliminary financial and operating results for the second quarter of 2026. The company sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the company's payer mix, which impacted revenue by approximately $400 million in the quarter. Following the news, HCA's stock price fell over 6%. Subsequently, Kessler Topaz Meltzer & Check, LLP (KTMC), a securities litigation law firm, announced it is investigating potential violations of federal securities laws by HCA on behalf of investors who purchased HCA securities and experienced significant losses. The investigation is ongoing, and no lawsuit has been filed at this time.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard